Gold Member Since 2015
Audited Supplier
Wuhan Wang Lianshang Biotechnology Co., Ltd.

Lenalidomide, Revlimi, Cc-5013 manufacturer / supplier in China, offering Lenalidomide / Revlimi CAS 191732-72-6 99% Purity API Anti-Cancers, Injectable Rip Cut Blend Steroid 175mg/Ml for Muscle Building, Bodybuilding Supplements Polypeptide Hormones Ipamorelin for Muscle Gain and so on.

(/ )

Supplier Homepage Product pharmaceutical intermediate Lenalidomide / Revlimi CAS 191732-72-6 99% Purity API Anti-Cancers

Lenalidomide / Revlimi CAS 191732-72-6 99% Purity API Anti-Cancers

FOB Price: US $1 / gram
Min. Order: 1 gram
Min. Order FOB Price
1 gram US $1/ gram
Get Latest Price
Port: Shanghai, China
Production Capacity: 300kg/Month
Payment Terms: T/T, Western Union, Money Gram

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: 191732-72-6
  • Customized: Customized
  • Suitable for: Adult
  • Purity: >99%
  • MW: 259.2606
  • Transport Package: 1kg / Foil Bag
  • Origin: China
  • Powder: Yes
  • Certification: GMP, USP, BP
  • State: Solid
  • Mf: C13h13n3o3
  • Trademark: wanglianshang
  • Specification: 99%
  • HS Code: 541514545
Product Description
Lenalidomide / Revlimi CAS 191732-72-6 99% Purity API Anti-Cancers 

English Name: Lenalidomide
Pharmacopoeia: Chinese Pharmacopoeia
CAS number: 191732-72-6
Molecular formula: C13H13N3O3
English synonyms: 3 - (7-amino-3-oxo-1h-isoindol-2-yl) piperidine-2,6-dione; LenalidomideLenalidomide; 1-Oxo-2- 2,6-dioxopiperidin-3-yl -4-aminoisoindoline; 3 - (4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl) -2,6-piperidinedione; CC-5013; Revlimi; lenalidomide (other anti-cancers); 3 4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl piperidine-2,6-dione
Molecular weight: 259.2606
Melting point: 269-271
Boiling point: 614 at C 760 mmHg
Density: at 5.2E-15mmHg 25 C
Flash point: 325.1 ~ C
Usage:Anti tumor

Lenalidomide Description:

Lenalidomide (initially known as CC-5013 and marketed as Revlimid® by Celgene) is a derivative of thalidomide introduced in 2004. It was initially intended as a treatment for multiple myeloma, for which thalidomide is an accepted therapeutic modality, but has also shown efficacy in the hematological disorders known as the myelodysplastic syndromes.FDA approved on December 27, 2005.

Medical uses:

(1) Multiple myeloma:

Multiple myeloma is a cancer of the blood, characterized by accumulation of a plasma cell clone in the bone marrow.Lenalidomide is one of the novel drug agents used to treat multiple myeloma. It is a more potent molecular analog of thalidomide, which inhibits tumor angiogenesis, tumor secreted cytokines and tumor proliferation through the induction of apoptosis.

(2) Myelodysplastic syndromes:

With myelodysplastic syndromes (MDS), the best results of lenalidomide were obtained in patients with deletion 5q.

It was approved by the FDA on December 27, 2005 for patients with low or intermediate-1 risk MDS with 5q- with or without additional cytogenetic abnormalities. A completed Phase II, multi-centre, single-arm, open-label study evaluated the efficacy and safety of Revlimid monotherapy treatment for achieving haematopoietic improvement in red blood cell (RBC) transfusion dependent subjects with low- or intermediate-1-risk MDS associated with a deletion 5q cytogenetic abnormality.

(3) Other cancers:

Lenalidomide is undergoing clinical trial as a treatment for Hodgkin's lymphoma,as well as non-Hodgkin's lymphoma, chronic lymphocytic leukemia and solid tumor cancers, such as carcinoma of the pancreas.One Phase 3 clinical trial being conducted by Celgene in elderly patients with B-cell chronic lymphocytic leukemia was halted in July 2013 when a disproportionate number of cancer deaths were observed during treatment with lenalidomide versus patients treated

Product name
191732-72-6Outer Packing
Production date
20151111Shelf life
Standard adopted
Enterprise Standard
Items of analysis
DescriptionOff-white to pale yellow powderConform 
SolubilitySlightly soluble in methanol and acetonitrileConform
Water(by K.F)≤4.0%0.37%
Residue on ignition≤0.1%0.04%
Related substancesAny single impurity≤0.1%0.02%
Particle size90% < 10 UM90% < 10 UM.
Assay(by non-aqueous)98.0-102.0%99.4%
Residual solventsDimethyl formamide≤880ppmConform

Packaging & Delivery:

1. Shipping by express (FedEx, UPS, DHL, EMS), by air; By ship.
2. Shipment will be arranged within 24 hours after receiving the payment;
3. Pictures of the package will be sent to you then along with the tracking number; Super discreet packaging, to ensure safe delivery, 99% successful delivery rate is ensured. Deliverytime:Alloftheorderswillbepackedwithin24hours after we get the payment usually it takes about3~5work days for you to get the parcel. Payment method: Bank wire, Western union, Moneygram
4. How to proceed order: First: Please let me know the itmes you are looking for, quantity, and the destination country. Second: You confirm all details, and offer us purchasing order; Third: We send the detail price of our product and offer the suitable shipping method for reference. Forth: You confirm the order and pay money 100% in advance and send us the detail address. Fifth: We arrange the shipment according to your requirements. Sixth: We offer after-sales service after you receive parcel
Send your message to this supplier
Mr. Cloud
Sales Manager
To: Mr. Cloud

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now